DossierENTITY

Vabysmo

Coverage of Vabysmo in the Nexus archive.

Earliest in view: Jul 23 · 05:26 UTCMost recent: Jul 23 · 05:26 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 23 · 05:26 UTCBLOOMBERG
Roche’s Second-Quarter Sales Held Back by Blockbuster Eye Drug
Roche Holding's second-quarter sales were impacted by a slower-than-expected recovery of its blockbuster eye drug Vabysmo. Investors are anticipating a key new drug to drive future growth.

Vabysmo · Dossier · The Nexus